Dezhan Healthcare Company Limited (SHE:000813)
China · Delayed Price · Currency is CNY 3.320
+0.030 (0.91%)
Jul 29, 2026, 3:04 PM CST
Dezhan Healthcare Company Company Description
Dezhan Healthcare Company Limited engages in the research and development, manufacture, and sale of cardiovascular and cerebrovascular drugs in the People’s Republic of China.
The company offers atorvastatin calcium tablets, amlodipine-atorvastatin calcium tablets, warfarin sodium tablets, trimetazidine hydrochloride tablets, amiodarone hydrochloride tablets, as well as other drugs, including famciclovir tablets, azathioprine tablets, hydroxyurea tablets, colchicine tablet, and oseltamivir phosphate capsules.
It also involved in the provision of biopeptides, industrial hemp, and medical service business. Dezhan Healthcare Company Limited was founded in 1980 and is based in Beijing, the People’s Republic of China.
Dezhan Healthcare Company Limited
| Country | China |
| Founded | 1980 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 1,067 |
| CEO | Wei Liu |
Contact Details
Address: First Shanghai Center Beijing, 100025 China | |
| Phone | 86 10 6585 8557 |
| Website | dezhanhealthcare.com |
Stock Details
| Ticker Symbol | 000813 |
| Exchange | Shenzhen Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE000000VV8 |
| SIC Code | 2200 |
Key Executives
| Name | Position |
|---|---|
| Wei Liu | Co-Chairman and GM |
| Jinghong Zhang | Deputy General Manager |
| Ling Wu | Chief Financial Officer |
| Lang Chen | Accounting Supervisor |
| Ye Liu | Chief Scientist |
| Tao Gao | Deputy GM, Director and Secretary of the Board |